Search

everythinglearnresearchcommunity

for

Search:↓

Advanced human skin models improve drug development and could replace animal testing.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Artificial skin is improving wound healing and shows potential for treating different types of wounds.

Adding human blood vessel cells to hair follicle germs may improve hair growth and quality.

Transplanted hair follicles can change and adapt to new areas of the body, with the immune system possibly playing a role in this adjustment.

Bioengineered teeth could replace damaged teeth and restore oral functions.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Low-dose UVB light improves hair growth effects of certain stem cells by increasing reactive oxygen species.

SFRP2 boosts Wnt3a/β-catenin signals in hair growth cells, with stronger effects in beard cells than scalp cells.

UV light helped human hair transplants survive in mice without broad immunosuppression.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Restoring nerve-macrophage communication may help treat autoimmune diseases.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Mesenchymal stem cell therapy shows promise for liver disease but faces challenges in standardization and approval.

Alopecia areata may protect against graft dysfunction, while asthma may increase its risk.

Mesenchymal stem cells can help repair body tissues with low risk of rejection.

iPSCs are promising for studying and treating COVID-19.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

The new technique effectively treats hairline vitiligo with repigmentation and hair regrowth.

FOXN1 mutations cause severe immunodeficiency, hair loss, nail issues, and thymus defects.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.